Exyn Technologies' Interim CEO Ben Williams will appear on FOX Business Network to discuss the company's physical AI technology, ExynAI®, and its applications in defense and national security. The company is also part of a U.S. Department of Energy initiative, the Mine of the Future, aimed at advancing domestic critical mineral discovery with $29.5 million in funding. Exyn's technology supports autonomous navigation in GPS-denied environments, enhancing mining and defense operations. This exposure highlights Exyn's growing role in critical infrastructure and energy independence efforts.
Exyn Technologies' Interim CEO Ben Williams is featured in this update. For readers following technology stocks, here is Pluang's market snapshot as of Oct 19, 2026 19:31 WIB: Out of 150 priced US technology stocks, 93 rose and 46 fell. Notable movers include Teradyne, Inc. (TER) at USD 341.36 with a 5.03% increase and a typical hold time of 38 days, ASE Technology Holding Co Ltd (ASX) at USD 41.49 with a 4.96% rise and a 49-day hold, and Credo Technology Group Holding Ltd (CRDO) at USD 177.83 with a 4.79% gain and a 23-day hold time.
Disc Medicine's stock surged 38% following positive Phase 3 trial results for its drug bitopertin, which showed efficacy and safety in treating erythropoietic protoporphyria. BMO Capital raised its price target from $100 to $120 and maintained an Out...
Qualcomm executive Ann C. Chaplin sold 1,827 shares of the company's stock for $319,268.25 under a Rule 10b5-1 trading plan, reducing her holdings by 6.62%. Qualcomm's stock price recently traded below its 50-day and 200-day moving averages, signalin...
BOK Financial is set to announce its Q3 2026 earnings after market close on October 19, with analysts forecasting earnings per share between $2.52 and $2.54 and revenue near $571 million. The company has a strong history of surpassing earnings estima...
AIBotics has completed the acquisition of NovaCore Labs' assets from PlayJamaica Limited, gaining technology, software, drones, mapping equipment, and customer contracts. This move expands AIBotics' platform in Jamaica and the Caribbean, enhancing AI...
EyePoint's stock dropped sharply after its DURAVYU treatment did not meet the primary endpoint in a Phase 3 trial for wet age-related macular degeneration (wet AMD). Although DURAVYU showed some vision improvement and reduced the need for additional ...
